This topic contains a solution. Click here to go to the answer

Author Question: A patient is admitted to the emergency room suffering from symptoms of alcohol withdrawal. The nurse ... (Read 71 times)

londonang

  • Hero Member
  • *****
  • Posts: 540
A patient is admitted to the emergency room suffering from symptoms of alcohol withdrawal. The nurse should plan care with the goal of preventing which of the following?
 
  A) Bradycardia
  B) Hypotension
  C) Seizures
  D) Gastrointestinal bleeding

Question 2

A patient with thalassemia requires frequent blood transfusions. The patient develops iron overload. Which of the following medications will be administered?
 
  A) Calcium gluconate
  B) Deferoxamine (Desferal)
  C) Sodium polystyrene sulfonate (Kayexalate)
  D) Deferasirox (Exjade)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

choc0chan

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

C
Feedback:
In acute alcohol withdrawal, a goal of treatment is to prevent seizures. Bradycardia is not the primary symptom of acute alcohol withdrawal. Hypotension is not the primary symptom of acute alcohol withdrawal. Gastrointestinal bleeding results from heavy alcohol use but is not the primary symptom of acute alcohol withdrawal.

Answer to Question 2

D





 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library